EUVIMEDEUVIMED entdecken
Crossref

Reliability and Validity of the Reachable Workspace Total Score With Wrist Weight in Facioscapulohumeral Muscular Dystrophy

Lena Hubig, Adi Eldar-Lissai, Siu Hing Lo, John Jiang iD, David Cella, Sarah Acaster

Muscle & Nerve · 2025

DOI: 10.1002/mus.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Lena Hubig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Acaster Lloyd Consulting Ltd., London, UK. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Activities of Daily Living, Wrist. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Fulcrum Therapeutics, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Facioscapulohumeral muscular dystrophy (FSHD) is characterized by relentlessly progressive muscular weakness, impacting patients' daily functioning, health‐related quality of life (HRQoL), and activities of daily living (ADLs), particularly those that require upper extremity (UE) function. Reachable workspace (RWS) is a performance outcome (PerfO) measure for UE function in FSHD. This study aimed to explore the reliability and validity of RWS average (for both arms) Total relative surface area (RSA) Q1–Q5 with 500 g wrist weight score (“Total Q1–Q5 RSA score”) in FSHD.

Methods

Data were sourced from the Phase 2 ReDUX4 clinical trial. Test–retest reliability and convergent validity of the Total Q1–Q5 RSA score were evaluated. The following outcome measures were included in the analyses: Timed up and go (TUG) and FSHD TUG, manual dynamometry, FSHD‐health index, patient's global impression of change, Ricci Clinical Severity Scale (CSS), and musculoskeletal magnetic resonance imaging (MRI).

Results

Almost perfect test–retest reliability (ICC = 0.98) and good convergent validity with moderate (| r | ≥ 0.3) correlations with most ADL items, clinical severity and UE muscle strength were shown.

Discussion

Psychometric evidence supports the reliability and validity of the Total RSA Q1–Q5 score as a measure of UE function in FSHD and contributes to the evidence for its use as an outcome in clinical trials of FSHD. Additional study is required to explore responsiveness to change.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralActivities of Daily LivingWristHumansMaleFemaleReproducibility of ResultsMiddle AgedAdultQuality of LifeAgedMuscle Strength

Stichwörter der Autor:innen

facioscapulohumeral muscular dystrophyperformance outcomes measurespsychometric validationreachable workspaceupper extremity function

Autor:innen und Institutionen

  • Acaster Lloyd Consulting Ltd., London, UK.
  • Fulcrum Therapeutics, Cambridge, Massachusetts, USA.
  • Department of Medical Social Science, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

ORCID-Profile: John Jiang

Förderung

  • Fulcrum Therapeutics, Inc.

Zitieren

APA

Hubig, L., Eldar-Lissai, A., Lo, S. H., Jiang, J., Cella, D., & Acaster, S. (2025). Reliability and Validity of the Reachable Workspace Total Score With Wrist Weight in Facioscapulohumeral Muscular Dystrophy. Muscle & Nerve. https://doi.org/10.1002/mus.70002

Vancouver

Hubig L, Eldar-Lissai A, Lo SH, Jiang J, Cella D, Acaster S. Reliability and Validity of the Reachable Workspace Total Score With Wrist Weight in Facioscapulohumeral Muscular Dystrophy. Muscle & Nerve. 2025. doi:10.1002/mus.70002

BibTeX
@article{Hubig2025,
  author = {Hubig, Lena and Eldar-Lissai, Adi and Lo, Siu Hing and Jiang, John and Cella, David and Acaster, Sarah},
  title = {Reliability and Validity of the Reachable Workspace Total Score With Wrist Weight in Facioscapulohumeral Muscular Dystrophy},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.70002}
}
Kostenlos starten →